Cipla to launch Entecavir tablet in USA
Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]
Pharmaceuticals
Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, […]
Marksans Pharma receives USFDA approval for Paricalcitol
Marksans Pharma has received USFDA approval for Paricalcitol capsules which are used for treating hyper parathyroidism. The Paricalcitol capsules are therapeutically equivalent to the reference […]
Shilpa Medicare receives USFDA approval for Azacitidine injection
Shilpa Medicare has received USFDA approval of Azacitidine injection which is used in the treatment of myelodysplastic syndrome. Myelodysplastic syndrome is a condition that affects […]
Jubilant Life Sciences receives USFDA approval for Darifenacin
Jubilant Life Sciences has received the final USFDA approval for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. The company has received Abbreviated […]
CTX Life Sciences to set up capsules unit in Karanj
CTX Life Sciences is setting up a tablets and capsules unit with a capacity of 6,000 tonne per annum at Karanj village, Mandvi taluka in […]
Jubilant Life Sciences receives USFDA approval for Telmisartan
Jubilant Life Sciences has received USFDA approval for Telmisartan Tablets, used for the treatment of hypertension, in the U.S. market. The final approval is for […]
Claris Lifescience receives USFDA approval for Flumazenil injection
Claris Lifesciences has received USFDA approval for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the United States. The company […]
Strides Shasun receives USFDA approval for Ranitidine
Strides Shasun has received USFDA approval for Ranitidine tablets. The drug Ranitidine is used to treat ulcers of the stomach and intestines and to prevent […]
Cipla receives final ANDA approval for Darifenacin extended-release
Cipla has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Darifenacin extended-release tablets. Darifenacin extended-release tablets are AB-rated generic equivalents of […]